日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas.

整合蛋白质组学和靶向下一代测序揭示了低级别脑膜瘤的相关异质性,并发现 ANXA3 是 NF2 突变脑膜瘤的新靶点

Shah Maryam, Akther Yeasmin, Adams Claire L, Banton Matthew C, Sharma Vikram, Ercolano Emanuela, Hilton David A, Kurian Kathreena M, Laraba Liyam, Woznica Waldemar, Parkinson David Bryan, de Assis Leandro José, Hanemann Clemens Oliver

The Spectrum of IDH- and H3-Wildtype High-Grade Glioma Subgroups Occurring across Teenage and Young Adult Patient Populations

青少年和青年患者群体中发生的IDH和H3野生型高级别胶质瘤亚组的谱系

Pereira, Rita; Mackay, Alan; Grabovska, Yura; Bradley, Amelia; Bloom, Tabitha; Nicoll, James; Boche, Delphine; Procter, John; Maybury, Mellissa; Schagen, Johanna; Walker, Liam; Roncaroli, Federico; Karabatsou, Konstantina; Ogunbiyi, Olumide; van Dalen, Thijs; Sidpra, Jai; Rossi, Sabrina; Miele, Evelina; Ziegler, David S; Shi, Zhifeng; Jacques, Thomas S; Hargrave, Darren; Zebian, Bassel; Bleil, Cristina; Yates, Joseph; Norton, Emma; Mandeville, Henry; Creak, Antonia; Welsh, Liam; Marshall, Lynley; Carceller, Fernando; Vaidya, Sucheta J; Reisz, Zita; Al-Sarraj, Safa; Mastronuzzi, Angela; Carai, Andrea; Vinci, Maria; Kurian, Kathreena M; Ng, Ho-Keung; Brandner, Sebastian; Jones, Chris; Clarke, Matthew

Defining the recommended gray zone in O6-methylguanine-DNA methyltransferase promoter methylation pyrosequencing reporting: A robust, translatable method to implement new EANO guidelines.

定义 O6-甲基鸟嘌呤-DNA 甲基转移酶启动子甲基化焦磷酸测序报告中推荐的灰色区域:一种稳健、可转化的方法来实施新的 EANO 指南

Taylor Polly, Cruickshank Gabrielle, Wildman Jack, Doyle George, Whittaker Ed, Walker Sara, McKeeve Claire, Faulkner Claire, Yarram-Smith Laura, White Paul, Kurian Kathreena M

Brain multi-omic Mendelian randomisation to identify novel drug targets for gliomagenesis

利用脑多组学孟德尔随机化方法鉴定胶质瘤发生的新型药物靶点

Thornton, Zak A; Andrews, Lily J; Zhao, Huiling; Zheng, Jie; Paternoster, Lavinia; Robinson, Jamie W; Kurian, Kathreena M

Evaluating liquid biopsy biomarkers for early detection of brain metastasis: A systematic review

评估液体活检生物标志物在脑转移早期检测中的应用:系统评价

Yu, Jinyue; Paterson, Craig; Davies, Phillippa; Palmer, Jennifer C; Higgins, Julian P T; Kurian, Kathreena M

Hypotonia, Ataxia, Developmental Delay and Tooth Enamel Defect Syndrome (HADDTS) due to a Heterozygous de Novo Missense Variant in CTBP1 Identified via Whole Genome Sequencing

通过全基因组测序鉴定出的CTBP1基因杂合新生错义变异导致肌张力低下、共济失调、发育迟缓和牙釉质缺陷综合征(HADDTS)。

Silvia Beatriz Sanchez Marco; Pardington, Emily; Monaghan, Marie; Spaull, Robert; Fadilah, Ala; Kurian, Kathreena; Vijayakumar, Kayal; Smithson, Sarah; Majumdar, Anirban

Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours

靶向作用于肿瘤细胞和巨噬细胞的 MERTK:对散发性和 NF2 相关脑膜瘤和神经鞘瘤的潜在干预措施

Foram Dave #, Kevin Herrera #, Alex Lockley, Laurien L van de Weijer, Summer Henderson, Agbolahan A Sofela, Laura Hook, Claire L Adams, Emanuela Ercolano, David A Hilton, Emmanuel A Maze, Kathreena M Kurian, Sylwia Ammoun #, C Oliver Hanemann #

Evaluating circulating tumour cell enrichment techniques to establish an appropriate method for clinical application in glioblastomas

评估循环肿瘤细胞富集技术以建立适用于胶质母细胞瘤临床应用的方法

Hannah R Barber, Claire M Perks, Kathreena M Kurian

Use of drugs for hyperlipidaemia and diabetes and risk of primary and secondary brain tumours: nested case-control studies using the UK Clinical Practice Research Datalink (CPRD)

使用高脂血症和糖尿病药物与原发性和继发性脑肿瘤风险的关系:基于英国临床实践研究数据链(CPRD)的嵌套病例对照研究

Robinson, Jamie W; Martin, Richard; Ozawa, Mio; Elwenspoek, Martha Maria Christine; Redaniel, Maria Theresa; Kurian, Kathreena; Ben-Shlomo, Yoav

Renal Clear Cell Carcinoma Masquerading As Brain Arteriovenous Malformation: A Case Report and Review of the Literature

肾透明细胞癌误诊为脑动静脉畸形:病例报告及文献复习

Fong, Yew Weng; Himel, Sean; Cernei, Cristina; Kurian, Kathreena; Banhisikha, Kanjilal; Wareham, James; Teo, Mario